ReviewAnalytical and bioanalytical chemistry2026
Microscale solid-phase extraction: advances in sorbent formats, system design, integration, and detection methods.
Review in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sample preparation is essential in chemical analysis as a critical determinant of analytical sensitivity, selectivity, and throughput, and is often the most resource-intensive stage of an analytical workflow. Microscale solid-phase extraction (µSPE) helps to address the sample preparation limitations associated with conventional SPE by enabling analyte enrichment and matrix cleanup at reduced volumes, with integration potential that traditional formats cannot match. This Critical Review assesses recent advances across six µSPE modalities: reverse-phase, ion exchange, immunoaffinity, aptamer-based, nucleic acid affinity, and magnetic particle, with attention to device preparation, detection integration, and performance metrics of each platform. Key enabling technologies for advancing µSPE, such as 3D printing, are described, and notable trends in the field are identified. Additionally, significant opportunities for future development in µSPE are discussed. Ongoing work positions µSPE as a foundational technology for advancing sample preparation and enhancing chemical analysis reliability.
Indexed as
Identifiers
42811207What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.